The effect of Brassica vegetables on blood glucose levels and lipid profiles in adults. A systematic review and meta‐analysis

Previous studies on the effect of Brassica vegetables on blood glucose and lipid profile have reported inconclusive findings. Due to the high prevalence of glucose and lipid metabolism disorders and their importance as predictors of chronic diseases, the present meta‐analysis was performed to clarify the effect of Brassica vegetables on blood glucose and lipid profile. A systematic search of the databases of PubMed, Scopus, and Cochran Library was performed up to October 2020. All randomized controlled trials (RCTs) that examined the effect of Brassica vegetables on blood glucose and lipid profile were included in the study. The search results were limited to English‐language publications. Finally, nine RCTs, including 548 participants, were selected for the present study. Pooled analysis indicated a significant reduction in total cholesterol (TC) (SMD = −0.28, 95%CI: 0.48 to 0.08; p = 0.005) following Brassica vegetables consumption. Overall, Brassica vegetables had no significant impact on serum levels of triglycerides, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol, fasting blood sugar, and glycated hemoglobin. Consumption of Brassica vegetables had a statistically significant effect on TC concentration. However, further high‐quality studies are needed to firmly establish the clinical efficacy of these plants.

[1]  A. Świergiel,et al.  Health Benefits of Plant-Derived Sulfur Compounds, Glucosinolates, and Organosulfur Compounds , 2020, Molecules.

[2]  A. Hernández-Almanza,et al.  The value of bioactive compounds of cruciferous vegetables (Brassica) as antimicrobials and antioxidants: A review. , 2020, Journal of food biochemistry.

[3]  E. Williamson,et al.  Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals , 2019, British journal of pharmacology.

[4]  C. Hajat,et al.  The global burden of multiple chronic conditions: A narrative review , 2018, Preventive medicine reports.

[5]  D. Laaksonen,et al.  Camelina Sativa Oil, but not Fatty Fish or Lean Fish, Improves Serum Lipid Profile in Subjects with Impaired Glucose Metabolism—A Randomized Controlled Trial , 2018, Molecular nutrition & food research.

[6]  R. Cooper,et al.  Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study , 2017, PloS one.

[7]  S. Friend,et al.  Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes , 2017, Science Translational Medicine.

[8]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[9]  D. Santoro,et al.  Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease , 2016, Journal of clinical & translational endocrinology.

[10]  E. M. Williamson,et al.  A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies , 2016, Phytotherapy research : PTR.

[11]  M. Kikuchi,et al.  Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects. , 2015, World journal of gastroenterology.

[12]  N. Laird,et al.  Meta-analysis in clinical trials revisited. , 2015, Contemporary clinical trials.

[13]  D. Mozaffarian,et al.  Changes in Intake of Fruits and Vegetables and Weight Change in United States Men and Women Followed for Up to 24 Years: Analysis from Three Prospective Cohort Studies , 2015, PLoS medicine.

[14]  M. Banach,et al.  Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel , 2015, Expert opinion on drug safety.

[15]  J. Potter,et al.  Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials , 2015, Molecular nutrition & food research.

[16]  M. Banach,et al.  Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel , 2015, Expert opinion on drug safety.

[17]  J. Tomassini,et al.  Combination therapy in dyslipidemia: where are we now? , 2014, Atherosclerosis.

[18]  F. Azizi,et al.  A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes , 2014, Journal of Diabetes & Metabolic Disorders.

[19]  Yichong Li,et al.  Risk factors for noncommunicable chronic diseases in women in China: surveillance efforts. , 2013, Bulletin of the World Health Organization.

[20]  J. Potter,et al.  A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function123 , 2013, The American journal of clinical nutrition.

[21]  Ji-Eun Kim,et al.  Randomized double-blind placebo-controlled trial of powdered Brassica rapa ethanol extract on alteration of body composition and plasma lipid and adipocytokine profiles in overweight subjects. , 2013, Journal of medicinal food.

[22]  F. Azizi,et al.  Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. , 2012, Diabetes research and clinical practice.

[23]  Hans Verhagen,et al.  Functional foods and dietary supplements: products at the interface between pharma and nutrition. , 2011, European journal of pharmacology.

[24]  L. Køber,et al.  Ingestion of Broccoli Sprouts Does Not Improve Endothelial Function in Humans with Hypertension , 2010, PloS one.

[25]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[26]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[27]  Vikram Patel,et al.  Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care , 2008, The Lancet.

[28]  X. Shu,et al.  Vegetable but not fruit consumption reduces the risk of type 2 diabetes in Chinese women. , 2008, The Journal of nutrition.

[29]  A. Theriault,et al.  Cruciferous indole-3-carbinol inhibits apolipoprotein B secretion in HepG2 cells. , 2007, The Journal of nutrition.

[30]  Sergio L. Schmukler,et al.  Emerging Market Instability : Do Sovereign Ratings Affect Country Risk and Stock Returns ? , 1997 .

[31]  F. Kaufman,et al.  Improvement in Risk Factors for Metabolic Syndrome and Insulin Resistance in Overweight Youth Who Are Treated With Lifestyle Intervention , 2006, Pediatrics.

[32]  H. Hauser,et al.  Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters , 2005, British Journal of Nutrition.

[33]  J. Manson,et al.  A prospective study of fruit and vegetable intake and the risk of type 2 diabetes in women. , 2004, Diabetes care.

[34]  Neil R. Powe,et al.  Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[35]  Ronald Klein,et al.  Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. , 2002, Diabetes care.

[36]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[37]  Walter C Willett,et al.  Dietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men , 2002, Annals of Internal Medicine.

[38]  Christian Gluud,et al.  Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses , 2001, Annals of Internal Medicine.

[39]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[40]  M. S. Patel,et al.  An introduction to meta-analysis. , 1989, Health Policy.

[41]  Sanlier,et al.  The Benefits of Brassica Vegetables on Human Health , 2018 .

[42]  A. Kopeć,et al.  The beneficial effects of Brassica vegetables on human health. , 2012, Roczniki Panstwowego Zakladu Higieny.

[43]  B. Patil,et al.  Crucial facts about health benefits of popular cruciferous vegetables , 2012 .

[44]  Jae Joon Lee,et al.  Effect of Broccoli Sprouts on Cholesterol-lowering and Anti-obesity Effects in Rats Fed High Fat Diet , 2009 .

[45]  Toshio Tanaka,et al.  Serum LDL-Cholesterol-Lowering Effects of a Mixed Green Vegetable and Fruit Beverage Containing Broccoli and Cabbage in Humans , 2008 .

[46]  A. Romani,et al.  Antiradical activity and polyphenol composition of local Brassicaceae edible varieties , 2006 .

[47]  W. Willett,et al.  Prevention of chronic disease by means of diet and lifestyle changes. , 2006 .

[48]  M. Uehara,et al.  Phase 1 study of multiple biomarkers for metabolism and oxidative stress after one‐week intake of broccoli sprouts , 2004, BioFactors.